The Health & Aging Brain Study – Health Disparities (HABS-HD) is a groundbreaking Alzheimer’s research initiative, focusing on brain aging and Alzheimer’s disease across diverse communities. It is the most comprehensive study of its kind, aiming to understand how health disparities impact brain health among different racial and ethnic groups.
Our team is enrolling 1,500 Hispanics, 1,500 non-Hispanic whites, and 1,500 African Americans aged 30 and older. All participants undergo an interview, memory testing, blood draw, functional exam, MRI of the brain, and PET scans for brain levels of amyloid (Alzheimer’s plaques) and tau (Alzheimer’s tangles).
The data from this study will be used to create a comprehensive picture of the biological, sociocultural, behavioral and environmental factors that impact the development, presence and progression of memory loss and AD across diverse communities.
Moreover, this is the first-ever large-scale study of Amyloid/Tau/Neurodegeneration pathological markers (and Framework) among a community-based, multi-ethnic cohort. This sets the stage for a precision medicine model that takes race and ethnicity into account when advancing novel diagnostics and therapeutics for treating and preventing Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) among diverse populations. To date, the HABS-HD study reflects the single largest collection of brain scans related to AD among diverse communities in history.